How are CRP Entzündung and menopause related?

The relationship between CRP (C-reactive protein) and menopause is well-recognized in medical literature, though not directly covered in the provided context. The key mechanism: estrogen decline during menopause reduces its anti-inflammatory effect, leading to a mild increase in baseline inflammation, reflected in slightly higher CRP levels. Observational studies (e.g., the SWAN study) consistently show that postmenopausal women have higher CRP than premenopausal women, independent of age and BMI. However, CRP is a non-specific marker – elevations can also stem from obesity, metabolic syndrome, or subclinical infection. The evidence is human-observational (moderate strength), not from RCTs. A single CRP test is not diagnostic for menopause. Women with elevated CRP during perimenopause should assess other cardiovascular risk factors (lipids, glucose, blood pressure). Genetic variants (e.g., in IL-6) influence baseline CRP, but the menopausal shift is usually larger. Caveat: CRP >3 mg/L indicates increased cardiovascular risk, which is already higher postmenopause. Hormone replacement therapy can lower CRP, but benefits must be weighed individually. In summary: the link is real but modest and confounded by lifestyle and metabolic factors.